Core Viewpoint - Rocket Doctor AI Inc. has increased its non-brokered private placement offering to a maximum of $4.5 million due to high demand, with each unit priced at $0.70 [1] Group 1: Offering Details - The offering has been upsized from its initial announcement on January 9, 2025, and the amended offering document is available on the company's profile and website [2] - All other terms of the offering remain unchanged despite the increase in the maximum gross proceeds [1] Group 2: Company Overview - Rocket Doctor AI Inc. provides AI-powered healthcare solutions designed to enhance accessibility throughout the patient journey, featuring the Global Library of Medicine (GLM) as a key component [4] - The company has empowered over 300 physicians to manage more than 700,000 patient visits, enabling doctors to launch and manage virtual or hybrid practices [5] - The technology aims to reduce administrative burdens, improve care consistency, and enhance physician-patient interactions, particularly targeting underserved communities in Canada and patients on Medicaid and Medicare in the U.S. [6]

Core Viewpoint - Traction Uranium Corp. has successfully closed a non-brokered private placement of unsecured convertible debentures, raising gross proceeds of C$500,000 [1] Group 1: Offering Details - The convertible debentures are issued in principal amounts of C$1,000 and will mature in 12 months, bearing an interest rate of 10% per annum, payable on the maturity date [2] - Each debenture can be converted into units at the holder's discretion, with the conversion price based on the most recent closing price of the company's common shares [3] - Each unit consists of one common share and one warrant, with the warrant allowing the holder to purchase one common share at an exercise price of 110% of the market price for 24 months [3] Group 2: Use of Proceeds - The net proceeds from the offering will be utilized for general and administrative expenditures and general working capital purposes [4] Group 3: Company Overview - Traction Uranium Corp. is engaged in mineral exploration and development, focusing on uranium projects in Canada, particularly in the Athabasca Region [6]

Core Viewpoint - ArrowMark Financial Corp. announced an estimated and unaudited Net Asset Value (NAV) of $21.96 as of December 31, 2025 [1] Company Overview - ArrowMark Financial Corp. is a non-diversified, closed-end fund listed on NASDAQ under the symbol "BANX" [2] - The investment objective of ArrowMark Financial is to provide shareholders with current income by primarily investing in regulatory capital securities of financial institutions [2] - The fund is managed by ArrowMark Asset Management, LLC [2]

Core Viewpoint - The Surface Transportation Board (STB) rejected the UP-NS merger application as incomplete, emphasizing the need for full and transparent disclosure in such significant transactions [1][2]. Group 1: Merger Application Details - The STB found that UP and NS did not meet basic requirements by failing to provide necessary information in their initial filing, indicating that the application was missing critical components [1][2]. - A stronger record is essential for the STB to assess whether the proposed merger serves the public interest and enhances competition, as the applicants withheld information crucial for understanding potential competitive harms [2]. Group 2: Company Position and Future Participation - CN expressed appreciation for the STB's thorough review and looks forward to robust participation once UP and NS submit a complete application, encouraging customers to stay informed and participate in the process [2][3]. - The company has been a key player in the transportation sector, moving over 300 million tons of goods annually across a nearly 20,000-mile rail network, contributing to sustainable trade and community prosperity since 1919 [4].

Core Viewpoint - GBank Financial Holdings Inc. is set to release its fourth quarter 2025 financial results on January 28, 2026, and will host a quarterly earnings call on the same day [1]. Company Overview - GBank Financial Holdings Inc. is a bank holding company based in Las Vegas, Nevada, listed on the Nasdaq Capital Market under the symbol "GBFH" [2]. - The company operates a national payment and Gaming FinTech business, serving gaming clients across the U.S. and offering the GBank Visa Signature Card tailored for the gaming and sports entertainment markets [2]. - GBank is recognized as a top national SBA lender, operating in 40 states, and has two full-service commercial branches in Las Vegas, Nevada, providing a range of banking products and services [2]. Investor Information - The company regularly posts important information for investors on its website, which is used for disclosing material non-public information and complying with SEC disclosure obligations [3]. - Investors are encouraged to monitor the company's website along with press releases, SEC filings, public conference calls, presentations, and webcasts for updates [3].

Core Viewpoint - DBV Technologies has successfully raised €166.7 million through the full exercise of ABSA and BS Warrants, which will support the launch of the VIASKIN® Peanut patch for children aged 4 to 7 years in the U.S., pending approval [1][11]. Financing Details - The financing involved the issuance of 34,090,004 ABSA Warrants and 71,005,656 BS Warrants, leading to the issuance of 59,657,507 new ordinary shares and up to 124,259,898 pre-funded warrants [1][5]. - The exercise price for the ABSA Warrants was €1.5939, while the BS Warrants had an exercise price of €1.5764 [1][6]. Use of Proceeds - The gross proceeds from the exercise will be utilized for working capital, general corporate purposes, and to finance the preparation and submission of a potential Biologics License Application (BLA) for the VIASKIN® Peanut patch [10][11]. - The total financing, including potential exercises of outstanding warrants, is estimated to reach approximately €284.5 million [10]. Shareholder Impact - The issuance of new shares will dilute existing shareholders' equity, with ownership interest for a shareholder holding 1.00% of the Company's share capital decreasing to 0.78% on a non-diluted basis after the issuance [15]. - The shareholding structure will change post-issuance, with Baker Brothers Investments retaining 8.64% and Janus Henderson acquiring 7.54% of the diluted share capital [17]. Company Overview - DBV Technologies is a late-stage biopharmaceutical company focused on developing treatments for food allergies using its proprietary VIASKIN® patch technology [19]. - The company is headquartered in Châtillon, France, with operations in North America [20].

Core Strategy - VERSES AI Inc. has announced a refocused corporate strategy aimed at concentrating resources on core target markets and high-priority initiatives [1][2] - The company aims to drive the best return on investment and benefit to shareholders through this strategic focus [3] Workforce Restructuring - The company is implementing a workforce restructuring that will reduce headcount by approximately 50% [2] - This reduction includes the termination of certain furloughed employees and executives not associated with core market activities [2] - Certain executives are temporarily deferring their salaries to support the company's strategy [2] Financial Impact - The restructuring is expected to drastically reduce operating costs and improve the company's liquidity position [2][5] - The leadership team believes that the actions taken will enhance efficiency and speed in pursuing core target markets [3]

VANCOUVER, British Columbia, Jan. 16, 2026 (GLOBE NEWSWIRE) -- SAGA Metals Corp. ("SAGA" or the "Company") (TSXV: SAGA) (OTCQB: SAGMF) (FSE: 20H), a North American exploration company focused on critical mineral discovery, is pleased to announce the assay results for two (2) additional diamond drill holes (R-0010 and R-0011) from the Company’s Q4 2025 Phase of the Mineral Resource Estimate (MRE) drill program in Trapper North at the Radar Ti-V-Fe Project, located near the port of Cartwright in Labrador, Can ...

Toronto, Ontario and Nucla, Colorado, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Western Uranium & Vanadium Corp. (CSE: WUC) (OTCQX: WSTRF) (“Western” or the “Company”) is pleased to provide the following updates. George Glasier, CEO Purchases Common Shares in the Open Market and Files Early Warning Report George Glasier, CEO, President, Founder and a director of the Company, announces that he acquired, for investment purposes, a total of 100,000 common shares of Western on December 29 and 30, 2025 at a price of CA ...

VANCOUVER, British Columbia, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) announces that it has completed a sale of its 99 acres of non-core land at 46 Ponderosa Drive in Christina Lake, British Columbia (the "Land"). Pursuant to the sale of the Land, the Company sold the bare un-serviced Land to an arm's length third party for aggregate gross proceeds of $551,000 (the "Sale Transaction"). The ...